Advantages of controlled- and sustained-release systems for pulmonary drug delivery
To treat both local and systemic lung diseases, pulmonary drug delivery (PDD) systems were recently introduced into the pharmaceutical field. PDD systems have been shown to deliver drugs directly to the required site in the body or to other distant sites via the bloodstream. Drugs are delivered to the lungs via pulmonary drug delivery systems to treat diseases of the respiratory tract. Because of the non-invasive technique, high blood circulation, large surface area for absorption, and permeability rate, this route is widely preferred. The growth is expected to be driven by an increase in the prevalence of chronic diseases such as bronchitis, tuberculosis, and chronic obstructive pulmonary disease, limitations of traditional treatments for pulmonary delivery, better penetrability of the drug, minimum dosage requirement, technological advancements, and an increase in smoking. What is the definition of pulmonary administration? The pulmonary route of administr...